D-TARGET SA Company Profile

14:23 EDT 21st June 2018 | BioPortfolio

Stratigically located in Switzerland, the heart of Europe, D-TARGET is the number one clinical research organisation specializing in Clinical and Regulatory Services throughout the European continent.
Medical device manufacturers worldwide rely upon D-TARGET's highly trained, multi-lingual professionals for result-oriented solutions in bringing their products to life in more than 25 European countries


En Chamard 55C



News Articles [203 Associated News Articles listed on BioPortfolio]

Performance on A&E target slips further

NHS hospital performance against the four-hour A&E target stood at just 74.96 percent, well under the 95 percent target, for the week ending March 11th, show the most recent data from the Royal Co...

Purification‐Free, Target‐Selective Immobilization of a Protein from Cell Lysates

Protein immobilization has been widely used for laboratory experiments and industrial processes. Preparation of a recombinant protein for immobilization usually requires laborious and expensive purifi...

Managing Expectations: "We're Still On Target" Says AstraZeneca CEO

Pascal Soriot says AstraZeneca remains on track to hit its $45bn sales target in 2023 – more or less -...   

AACR18: Day 1 Cancer & Immunology Symposium

We often talk about ‘on-target off-target’ side effects, but what about the equivalent on-site off-the-reservation meetings?  I’m a big fan…

Bristol-Myers Squibb (BMY) Raised to "Overweight" at Morgan Stanley

The firm presently has a $78.00 target price on the biopharmaceutical company's stock, up from their previous target price of $51.56. Morgan Stanley's target price suggests a potential upside ...

Engineered Anthrax Toxin Variants that Target Cancer

This technology describes the use of novel mutated anthrax protective antigen (PA) protein variants to target tumor cells and tumor vasculature. NIH scientists have engineered two PA variants that se...

Molecular Trojan horse delivers chemotherapeutic drug to cancer cells

Researchers have discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases. Until now, paclitax...

CRISPR-Cas9 Used to Knock Out Genes in Robusta Coffee

Scientists Jean-Christophe Breitler from French Agricultural Research Centre for International Development and colleagues developed a web tool to identify all gRNA target sequences in the robusta coff...

PubMed Articles [702 Associated PubMed Articles listed on BioPortfolio]

Effects of seed mixture sowing with resistant and susceptible rice on population dynamics of target planthoppers and non-target stemborers and leaffolders.

The widespread planting of insect-resistant crops has caused a dramatic shift in agricultural landscapes, thus raising concerns about the potential impact on both target and non-target pests worldwide...

SeedVicious: Analysis of microRNA target and near-target sites.

Here I describe seedVicious, a versatile microRNA target site prediction software that can be easily fitted into annotation pipelines and run over custom datasets. SeedVicious finds microRNA canonical...

What is the optimal target for treat-to-target strategies in rheumatoid arthritis?

There has been a trend over time to aim for stricter treatment targets in the treatment of rheumatoid arthritis (RA). We reviewed recent literature to attempt to identify the optimal target in treat-t...

Substantial heterogeneity in progress towards reaching the 90-90-90 HIV target in the WHO European Region.

Achieving the UNAIDS 90-90-90 target by 2020 is expected to end the HIV epidemic by 2030. We report on progress in the WHO European Region in meeting this target.

Abundant off-target edits from site-directed RNA editing can be reduced by nuclear localization of the editing enzyme.

Site-directed RNA editing (SDRE) is a general strategy for making targeted base changes in RNA molecules. Although the approach is relatively new, several groups, including our own, have been working ...

Clinical Trials [1582 Associated Clinical Trials listed on BioPortfolio]

Preliminary Investigation of optimaL Oxygen Targets Trial

Mechanical ventilation of ICU patients universally involves titration of the fraction of inspired oxygen (FiO2) to maintain arterial oxygen saturation (SpO2). Despite decades of ICU practi...

Treat Stroke to Target

The aim of this study is the evaluation of two usual care strategies after stroke or TIA : achieved target LDL-C of 100 mg/dL (+/-10 mg/dL) or less than 70 mg/dL. Investigators will use th...

Reduction of Remifentanil-related Complications by Limiting Maximum Plasma Concentration During Target-controlled Infusion

This study is intended to evaluate the effect of decreasing the maximum plasma concentration target of remifentanil of the Target Controlled Infusion system on the the incidence of major a...

BP-TARGET : Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy

A randomized, multicenter study comparing two strategies: 1 / standard management of systolic blood pressure according to international recommendations (systolic blood pressure

Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)

In this study the effect of the switch to rosuvastatin from another statin (fluvastatin, pravastatin, simvastatin, atorvastatin) was evaluated in high-risk patients with and without eviden...

Companies [604 Associated Companies listed on BioPortfolio]

Target Health Inc. & LifeOnKey Inc.

Target Health, ( established in 1993, is a full service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of exp...

Target Corp.

Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,764 stores across the United States and at The company plans to open its first stores in Canada in 2...

Target Corporation

Minneapolis-based Target Corporation (NYSE: TGT) serves guests at 1,699 stores in 49 states nationwide and at Target is committed to providing a fun and convenient shopping experience with...

Target BioScience AG

Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founde...


Stratigically located in Switzerland, the heart of Europe, D-TARGET is the number one clinical research organisation specializing in Clinical and Regulatory Services throughout the European continent....

More Information about "D-TARGET SA" on BioPortfolio

We have published hundreds of D-TARGET SA news stories on BioPortfolio along with dozens of D-TARGET SA Clinical Trials and PubMed Articles about D-TARGET SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of D-TARGET SA Companies in our database. You can also find out about relevant D-TARGET SA Drugs and Medications on this site too.

Quick Search


Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Corporate Database Quicklinks

Searches Linking to this Company Record